Why BioNTech Was a Top Coronavirus Stock on Tuesday
BioNTech (NASDAQ: BNTX) rose 4.8% on Wednesday without reporting any news on its own. Rather, it was the latest from a fellow coronavirus vaccine developer that propelled the shares skyward.
BioNTech has lately become (relatively) famous because the biotech has teamed up with big pharmaceutical company Pfizer (NYSE: PFE) in the high-stakes coronavirus vaccine development race. The two companies announced Monday that their BNT162b2 has begun a "rolling review" with regulator Health Canada.
Image source: Getty Images.
Source Fool.com
